News
MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its ...
BOSTON--(BUSINESS WIRE)--Akoya, a 100% API-connected data access network, announced today an agreement with leading data access platform Envestnet | Yodlee, to help consumers more efficiently ...
Akoya Biosciences has seen a significant decline in its stock price but has recently bounced back by 55%. The company has shown consistent revenue growth over the past four years, with a projected ...
In light of the pending acquisition by Quanterix Corporation, Akoya will not be hosting an earnings conference call or providing forward-looking guidance at this time. This communication shall not ...
Hosted on MSN24d
Quanterix targets $120M–$130M FY25 revenue while scaling Simoa ONE and revising Akoya merger terms amid funding headwindsAfter the Akoya deal closes, the expected cash balance at the end of Q2 is approximately $160 million, and "we expect to achieve cash flow breakeven as a combined company in 2026, and we expect to ...
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Monday reported a loss of $15.7 million in its first quarter. The Marlborough, Massachusetts-based company ...
Marlborough firm Akoya Biosciences has eliminated two C-suite positions as part of an initiative to cut its expenses, as it aims to raise $43.5 million in additional funding. The company’s chief ...
Quanterix and Akoya Biosciences amended the terms of their merger due to economic volatility. Quanterix, a biomarker detection company, will now issue about 7.76 million shares of its common stock ...
MARLBOROUGH, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results